Ad Header



The Pulse of the Pharmaceutical Industry

French court dismisses damages claims against Merck

Written by: | | Dated: Tuesday, March 5th, 2019


French court dismisses damages claims against Merck over thyroid drug


LYON, France (Reuters) – A court in the French city of Lyon threw out on Tuesday claims made by 4,113 plaintiffs for damages against Merck over changes to its thyroid drug Levothyrox.

The plaintiffs had accused Merck of not providing sufficient information regarding changes to the product.

They had said Merck’s decision to remove lactose from the drug to make it easier to handle had resulted in side effects such as memory loss, weight gain and palpitations, but the Lyon court ruled in favor of Merck.


Reporting by Catherine Lagrange; Editing by Sudip Kar-Gupta/Yves Clarisse


Reuters source:

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom